Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
Proactively manage your pharmacy inventory
Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Anticipate generic drug launch
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Amino acid analogs for tumor imaging|
|Abstract:||The invention provides novel amino acid compounds of use in detecting and evaluating brain and body tumors. These compounds combine the advantageous properties of 1-amino-cycloalkyl-1-carboxylic acids, namely, their rapid uptake and prolonged retention in tumors with the properties of halogen substituents, including certain useful halogen isotopes including fluorine-18, iodine-123, iodine-125, iodine-131, bromine-75, bromine-76, bromine-77 and bromine-82. In one aspect, the invention features amino acid compounds that have a high specificity for target sites when administered to a subject in vivo. Preferred amino acid compounds show a target to non-target ratio of at least 5:1, are stable in vivo and substantially localized to target within 1 hour after administration. An especially preferred amino acid compound is [.sup.18 F]-1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC). In another aspect, the invention features pharmaceutical compositions comprised of an .alpha.-amino acid moiety attached to either a four, five, or a six member carbon-chain ring. In addition, the invention features analogs of .alpha.-aminoisobutyric acid.|
|Inventor(s):||Goodman; Mark M. (Atlanta, GA), Shoup; Timothy (Decatur, GA)|
|Assignee:||Emory University (Atlanta, GA)|
|Filing Date:||Nov 08, 1996|
|Claims:||1. An amino acid analog having the general structure |
where R is ##STR24## where a is 1, 2 or 3 b is 0, 1 or 2
x is 0 or 1
y is 1 or 2
z is 1,2,3 or 4 and z>y if y is 2,
q is 1 or 0
Z is ##STR25##
2. A compound according to claim 1 wherein Z is ##STR26##
3. A compound according to claim 2 wherein a is 1, 2 or 3 and b is 0.
4. A compound according to claim 2 wherein a is 1, 2 or 3 and b is 1.
5. A compound according to claim 2 wherein a is 1, 2 or 3 and b is 2.
6. A compound according to claim 2 wherein Z is ##STR27##
7. A compound according to claim 6 wherein a is 1, 2, or 3 and b is 0.
8. A compound according to claim 6 wherein a is 1, 2 or 3 and b is 1.
9. A compound according to claim 6 wherein a is 1, 2 or 3 and b is 2.
10. A compound according to claim 2 wherein Z is ##STR28##
11. A compound according to claim 10 wherein a is 1, 2, or 3 and b is 0.
12. A compound according to claim 10 wherein a is 1, 2, or 3 and b is 1.
13. A compound according to claim 10 wherein a is 1, 2, or 3 and b is 2.
14. A method of in situ tumor imaging by single photon emission tomography comprising:
administering to a subject suspected of having a tumor an image-generating amount of a compound according to claim 1, and
measuring the distribution of the compound in the subject by single photon emission tomography.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.